UOC ONCOLOGICAL ORTHOPAEDICS
Head: Roberto Biagini, MD
STAFF
- Leonardo Favale
- Nicola Salducca
- Carmine Zoccali (PhD)
- Barbara Rossi
- Jacopo Baldi
- Dario Attala
- Alessandro Grò
- Beatrice Calabrese
- Wioletta Faltyn
- Elisa Checcucci
- Giovanni Meogrossi
- Grazia Amato
- Paolo Asquini
- Daniele Cacciarelli
- Fabio Conti
- Antonella Cutini
- Carolina Destito
- Monica Barrucci
- Sabrina Ganzenua
- Stefano Landi
- Alessia Milotti
- Casula Alex
- De Martino Stefania
SARCOMA TROBS Trabectedin in Soft Tissue Sarcomas a retrospective analysis.
Observational study: ISG-STS 10.01 Localized high-risk soft tissue sarcomas of the extremities and trunk wall in adults: an integrating approach comprising standard vs histotype-tailored neoadjuvant Chemotherapy.
Phase III: closed at the moment jun-2016 2 19 ISG-OS-02 Multicentric, prospective, randomized clinical trial in patients with recurrence of osteosarcoma.
Phase III: open 5 -15 ISG/AIEOP EW1 Phase III trial on the efficacy of dose intensification in patients with non-metastatic Ewing Sarcoma.
Phase III: open 2 -8 RECURR International Randomised controlled trial of Chemotherapy for the treatment of recurrent and primary refractory Ewing Sarcoma Phase II/III.
Sacral Chordoma – IT: Randomised and observational study between surgery and radiotherapy in the localized primitive disease (SACRO)
Naobiotix n. 301: Studio multicentrico, randomizzato, in aperto, di fase II/III per confrontare l’efficacia di NBTXR3, impiantato con iniezione intratumorale e ttivo mediante radioterapia, risposto alla sola radioterapia, in pazienti affetti da Sarcoma della parete dei tessuti molli degli arti e del tronco, localmente avanzato.
EORTC-1553-SPECTA: invitation to join SPECTA for rare cancers (in collaboration with EURACAN/ROCHE)
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access